Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aion Therapeutic Inc C.AION

Alternate Symbol(s):  ANTCF

Aion Therapeutic Inc is in the business of research and development, treatment, data mining and state-of-the-art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery.


CSE:AION - Post by User

Aion Therapeutic Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(10)
•••
Post by RisePrize007on Jan 11, 2024 10:32am
103 Views
Post# 35821334

Little Green Pharma kicks off WA psychedelic trails

Little Green Pharma kicks off WA psychedelic trailsLittle Green Pharma  attached entity Reset Mind Sciences (RMS) has officially kicked off a WA-based trial investigating the use of psilocybin in patients with treatment-resistant depression https://themarketherald.com.au/little-green-pharma-kicks-off-wa-psychedelic-mental-health-trial-2024-01-11/amp/
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities